Work

Supplementary Figure from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figure from Sunvozertinib, a Selective EGFR Inhibitor for Previously Treated Non–Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4362556062
Cites:
Cited by:
Related to: 10